Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, November 7, 2026

Back to the front page

Post Q3 EVC Update

EVC's Q3 update cites $30 million for a single station, a broadcast-business sale and stronger positioning for 2027.

EVC $832M
Nat Stewart - Stock Picking Newsletter 23 clicks

From X

@MaiusPartners 1 click

Maius on X

$PSIX Q3 results and recent power sector thoughts: The company delivered an exceptional Q3 clean “beat and raise” by any measure — even better than the record Q2 2025, when the stock peaked at over $100, with a much better story today. Yet the stock trades at a fraction of the valuation, Why? Long-term followers know we turned constructive on $PSIX only recently after an extensive amount of fundamental work and have not been afraid to be critical in the past. It was a meaningful position heading into the print. Given broader sector risks, we also held several related short positions as a factor hedge. However, after analysing $ANT S1 filings and election results, we think the narrative has shifted materially over the past week and when the facts change, it’s always important to reassess one’s central beliefs and have opted to close the majority of the long positions in $PSIX (retaining an OTM call option), while keeping all the shorts. The high level math: ~30 GW of behind-the-meter power capacity is scheduled to become available in 2027, scaling to >100 GW by 2030 if the dozen suppliers deliver on announced expansions (many won’t). Absent major changes in U.S. politics or AI model diffusion rates to support far higher collective monetisation rates across the entire industry, rapid buildout of new data centres on American soil can neither be justified economically, nor politically, a view held by the credit markets for some time, but only just beginning to be priced in by equity investors. The behind the meter power industry risks moving quickly into excess in such a scenario, with incremental suppliers at especially high risk. $PSIX has been one of the top-performing behind-the-meter power plays we track since our recent full note. Its unfortunate market conditions changed so quickly, substantially reducing the probability of developing into the multi-bagger we envisioned. Congrats to everyone who made money in this sector the past few months, it certainly hasn’t been easy (especially on the long side!) — and have a great weekend! DMs always open for those wanting to discuss further.
@Mr_Neutral_Man 1 click

Mr Neutral Man aka "Howard Marks of REITs” on X

Not denying nor confirming my VIC identity and I generally would refrain from doxxxing That write up had zero mention of tax analysis which is why funds can't own it. Buying $1mm of $ARI could result in $520k to $833k of cap gain in 2026 before you get any distribution. IMO, whoever ranted against that write up is doing all the members a tremendous service. I personally did a week worth of work on it and talked to some of the smartest folks about REIT liquidations and taxes. I finally found a solution that I feel comfortable with. I didn't buy it in the fund I manage due to the 2026 cap gains. But I found a bespoken solution that I think works for me
Mr Neutral Man aka "Howard Marks of REITs” ARI $310M

Investor Letters

All letters

GREAT DEC-TECTIVE WORK

Diversified Energy reported $255.6 million of “true” nine-month free cash flow, while its $1.8 billion Birch acquisition would shift…

DEC $900M
The Oak Bloke 2 clicks

Research Note

Nine Mile Metals is the subject of a research note.

VMSXF $14M
Atrium Research - Equity Research 4 clicks

Site Centers (NYSE:SITC)

Site Centers' $3 per-share return-of-capital distribution and December delisting leave a discounted liquidation stub, with two properties…

SITC $192M
Real Assets, Real Value 4 clicks

Namib Minerals: Research Flash

Namib Minerals accelerates Redwing’s restart, targeting first gold this month and a ramp from 338 ounces monthly to 835 ounces by Q2 2027.

NAMM $46M
Atrium Research - Equity Research 6 clicks
OPRX · long

Optimizerx CORP

OptimizeRx, OPRX, trades 30% below its February 2025 writeup despite becoming a stronger company.

OPRX $163M
Value Investors Club 2 clicks

SCIA- SCI Engineered Materials

SCIA generates $28 million of revenue from thin-film materials, with 78% of sales tied to one customer, while expanding into defense…

SCIA $42M
Sylence Capital

ALTO- ALTO ingredients

ALTO Ingredients trades near half of book value after plant upgrades and lower corn prices set up a recovery in crush margins and cash flow.

ALTO $285M
Sylence Capital 1 click

Notes and Updates

ECIP recipient banks could repurchase Treasury preferred shares at steep discounts, potentially lifting book value, while Hawaiian Electric…

UBAB $189M
Exploring with Alluvial Capital

Mereo Biopharma

Mereo Biopharma has two late-stage assets, seeks non-dilutive financing for alvelestat Phase 3 trials, and reports cash runway through 2027.

MREO $44M
Raging Bull Investments

Revisiting An Old Idea

Instil Bio leased its 128,000-square-foot Tarzana life-sciences building to AstraZeneca for 15 years at $7.52 million annual rent,…

TIL $47M
Raging Bull Investments

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 277

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.